Application of probabilistic multiple-bias analyses to a cohort- and a case-control study on the association between Pandemrix™ and narcolepsy

PLoS ONE

Volumn 11, Issue 2, 2016, Pages

  Bollaerts, Kaatje ^a   Shinde, Vivek ^b   Dos Santos, Gaël ^c   Ferreira, Germano ^c   Bauchau, Vincent ^c   Cohet, Catherine ^c   Verstraeten, Thomas ^a  

^a Pharmacovigilance and Epidemiology Services ^*  (Belgium)

^b GLAXOSMITHKLINE   (United States)

^c GSK   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE CLASSIFICATION; EVIDENCE BASED MEDICINE; FRANCE; HUMAN; INFLUENZA A (H1N1); MONTE CARLO METHOD; MULTIPLE BIAS ANALYSIS; NARCOLEPSY; PROCESS DEVELOPMENT; QUANTITATIVE ANALYSIS; SELECTION BIAS; STATISTICAL MODEL; CHEMICALLY INDUCED; FEMALE; FINLAND; INFLUENZA A VIRUS (H1N1); INFLUENZA, HUMAN; MALE; PANDEMIC; PRESCHOOL CHILD; SWEDEN;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; FINLAND; FRANCE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; NARCOLEPSY; PANDEMICS; SWEDEN;

EID: 84960539161     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0149289     Document Type: Article

References (48)

1. WHO (2010) Evolution of a pandemic: A(H1N1) 2009, April 2009-March 2010. Geneva: World Health Organisation.
2. WHO (2009) Recommendations of the Strategic Advisory Group of Experts (SAGE) on Influenza A (H1N1) vaccines; 19 May 2009.
3. ECDC (2012) Narcolepsy in association with pandemic influenza vaccination. A multi-country European epidemiological investigation. Stockholm.
4. THL (2010) National Institute for Health and Welfare recommends discontinuation of Pandemrix vaccinations.
5. Lakemedelsverket (Medical Products Agency) (2010) The MPA investigates reports of narcolepsy in patients vaccinated with Pandemrix.
6. Ahmed I and Thorpy M (2010) Clinical features, diagnosis and treatment of narcolepsy. Clin Chest Med 31:371-381. doi: 10.1016/j.ccm.2010.02.014 PMID: 20488294
7. Tafti M, Hor H, Dauvilliers Y, Lammers GJ, Overeem S, Mayer G, et al. (2014) DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe. Sleep 37:19-25. doi: 10.5665/sleep.3300 PMID: 24381371
8. Aran A, Lin L, Nevsimalova S, Plazzi G, Hong SC, Weiner K, et al. (2009) Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset. Sleep 32:979-983. PMID: 19725248
9. Han F, Lin L, Warby SC, Faraco J, Li J, Dong SX, et al. (2011) Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann Neurol 70:410-417. doi: 10.1002/ana. 22587 PMID: 21866560
10. Han F, Lin L, Li J, Dong XS and Mignot E (2012) Decreased incidence of childhood narcolepsy 2 years after the 2009 H1N1 winter flu pandemic. Ann Neurol 73:560. doi: 10.1002/ana.23799 PMID: 23225098
11. Bardage C, Persson I, Ortqvist A, Bergman U, Ludvigsson JF and Granath F (2011) Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden. BMJ 343:d5956. doi: 10.1136/bmj.d5956 PMID: 21994316
12. O'Flanagan D, Barret AS, Foley M, Cotter S, Bonner C, Crowe C, et al. (2014) Investigation of an association between onset of narcolepsy and vaccination with pandemic influenza vaccine, Ireland April 2009-December 2010. Eurosurveillance 19.
13. Dauvilliers Y, Arnulf I, Lecendreux M, Monaca Charley C, Franco P, Drouot X, et al. (2013) Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France. Brain 136:2486-2496. doi: 10.1093/brain/awt187 PMID: 23884811
14. Heier MS, Gautvik KM, Wannag E, Bronder KH, Midtlyng E, Kamaleri Y, et al. (2013) Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A. Sleep Med 14:867-871. doi: 10.1016/j.sleep.2013.03.020 PMID: 23773727
15. Miller E, Andrews N, Stellitano L, Stowe J, Winstone AM, Shneerson J, et al. (2013) Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis. BMJ 346:f794. doi: 10.1136/bmj.f794 PMID: 23444425
16. Nohynek H, Jokinen J, Partinen M, Vaarala O, Kirjavainen T, Sundman J, et al. (2012) AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS One 7:e33536. doi: 10.1371/journal.pone.0033536 PMID: 22470453
17. Partinen M, Saarenpaa-Heikkila O, Ilveskoski I, Hublin C, Linna M, Olsen P, et al. (2012) Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS One 7:e33723. doi: 10.1371/journal.pone.0033723 PMID: 22470463
18. Persson I, Granath F, Askling J, Ludvigsson JF, Olsson T and Feltelius N (2013) Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a populationand registry-based cohort study with over 2 years of follow-up. J Intern Med 275:172-190. doi: 10.1111/joim.12150 PMID: 24134219
19. Szakacs A, Darin N and Hallbook T (2013) Increased childhood incidence of narcolepsy in western Sweden after H1N1 influenza vaccination. Neurology 80:1315-1321. doi: 10.1212/WNL. 0b013e31828ab26f PMID: 23486871
20. Sturkenboom MC (2015) The narcolepsy-pandemic influenza story: Can the truth ever be unraveled? Vaccine 33 Suppl 2:B6-B13. doi: 10.1016/j.vaccine.2015.03.026 PMID: 26022571
21. Verstraeten T, Cohet C., Dos Santos G., Ferreira G.L.C., Bollaerts K., Bauchau V., Shinde V. (2015) Pandemrix and narcolepsy: a critical appraisal of the observational studies. Human vaccines and immunotherapeutices in press.
22. Greenland S (2005) Multiple-bias modelling for analysis of observational data. Journal of the Royal Statistical Society: Series A (Statistics in Society) 168:267-306.
23. Lash TL, Fox MP, MacLehose RF, Maldonado G, McCandless LC and Greenland S (2014) Good practices for quantitative bias analysis. Int J Epidemiol 43:1969-1985. doi: 10.1093/ije/dyu149 PMID: 25080530
24. Lash TLF, M.P.;Fink A.K. (2009) Applying Quantitative Bias Analysis to Epidemiologic Data. New York: Springer.
25. US Food and Drug Administration (FDA) (2013) Best Practices for Conducting and Reporting Pharmacoepidemiologic Safety Studies Using Electronic Healthcare Data [Internet].
26. The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) (2010) Guide on Methodological Standards in Pharmacoepidemiology (Revision 2).
27. Greenland S (1996) Basic methods for sensitivity analysis of biases. Int J Epidemiol 25:1107-1116. PMID: 9027513
28. Groenwold RH, Nelson DB, Nichol KL, Hoes AW and Hak E (2010) Sensitivity analyses to estimate the potential impact of unmeasured confounding in causal research. Int J Epidemiol 39:107-117. doi: 10.1093/ije/dyp332 PMID: 19948779
29. Phillips CV (2003) Quantifying and reporting uncertainty from systematic errors. Epidemiology 14:459-466. PMID: 12843772
30. Schneeweiss S (2006) Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics. Pharmacoepidemiol Drug Saf 15:291-303. PMID: 16447304
31. Steenland K and Greenland S (2004) Monte Carlo sensitivity analysis and Bayesian analysis of smoking as an unmeasured confounder in a study of silica and lung cancer. Am J Epidemiol 160:384-392. PMID: 15286024
32. Poli F, Overeem S, Lammers GJ, Plazzi G, Lecendreux M, Bassetti CL, et al. (2013) Narcolepsy as an adverse event following immunization: case definition and guidelines for data collection, analysis and presentation. Vaccine 31:994-1007. doi: 10.1016/j.vaccine.2012.12.014 PMID: 23246545
33. R Development Core Team (2013) R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing.
34. Vose D (2008) Risk analysis: a quantitative guide. Wiley: Chichester, England.
35. MPA (2011) Report from an epidemiological study in Sweden on vaccination with Pandemrix and narcolepsy. Stockholm: Läkemedelsverket.
36. Wijnans L, Lecomte C, de Vries C, Weibel D, Sammon C, Hviid A, et al. (2013) The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns. Vaccine 31:1246-1254. doi: 10.1016/j.vaccine.2012.12.015 PMID: 23246544
37. Xu C, Bai T, Iuliano AD, Wang M, Yang L, Wen L, et al. (2011) The seroprevalence of pandemic influenza H1N1 (2009) virus in China. PLoS One 6:e17919. doi: 10.1371/journal.pone.0017919 PMID: 21533034
38. Van Kerkhove MD, Hirve S, Koukounari A, Mounts AW and group HNpsw (2013) Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries. Influenza Other Respir Viruses 7:872-886. doi: 10.1111/irv.12074 PMID: 23331969
39. Shubin M, Virtanen M, Toikkanen S, Lyytikainen O and Auranen K (2014) Estimating the burden of A (H1N1)pdm09 influenza in Finland during two seasons. Epidemiol Infect 142:964-974. doi: 10.1017/S0950268813002537 PMID: 24139316
40. Lyytikainen O, Kuusi M, Snellman M, Virtanen M, Eskola J, Ronkko E, et al. (2011) Surveillance of influenza in Finland during the 2009 pandemic, 10 May 2009 to 8 March 2010. Euro Surveill 16.
41. Llupia A, Garcia-Basteiro AL, Mena G, Rios J, Puig J, Bayas JM, et al. (2012) Vaccination behaviour influences self-report of influenza vaccination status: a cross-sectional study among health care workers. PLoS One 7:e39496. doi: 10.1371/journal.pone.0039496 PMID: 22808039
42. Bone A, Guthmann JP, Nicolau J and Levy-Bruhl D (2010) Population and risk group uptake of H1N1 influenza vaccine in mainland France 2009-2010: results of a national vaccination campaign. Vaccine 28:8157-8161. doi: 10.1016/j.vaccine.2010.09.096 PMID: 20937310
43. INSERM (2012) Etude NarcoFlu-VF. (NarcoFlu VAESCO-France) Rapport Final.
44. Caille-Brillet AL, Raude J, Lapidus N, De Lamballerie X, Carrat F and Setbon M (2013) Trends in influenza vaccination behaviours-results from the CoPanFlu cohort, France, 2006 to 2011. Euro Surveill 18:20628. PMID: 24229790
45. Thorpy MJ and Krieger AC (2014) Delayed diagnosis of narcolepsy: characterization and impact. Sleep Med 15:502-507. doi: 10.1016/j.sleep.2014.01.015 PMID: 24780133
46. MPA (2011) Läkemedelsverket. Medical Products Agency. Occurrence of narcolepsy with cataplexy among children and adolescents in relation to the H1N1 pandemic and Pandemrix vaccinations-Results of a case inventory study by the MPA in Sweden during 2009-2010. Report no. 1. Sweden. pp. 1-20.
47. Pizza F, Peltola H, Sarkanen T, Moghadam KK, Plazzi G and Partinen M (2014) Childhood narcolepsy with cataplexy: comparison between post-H1N1 vaccination and sporadic cases. Sleep Med 15:262-265. doi: 10.1016/j.sleep.2013.09.021 PMID: 24468101
48. Greenland S, Lash T.L. (2008) Bias analysis. In: Rothman K. J., Greenland S, Lash T.L., editors. Modern Epidemiology, 3d edition. Lippincott Williams & Wilkins.